Back to top
more

Edwards Lifesciences (EW)

(Real Time Quote from BATS)

$77.47 USD

77.47
2,030,189

-1.14 (-1.45%)

Updated Aug 7, 2025 03:40 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (147 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Will Walgreens' (WBA) Q2 Earnings Gain From Overall Growth?

by Zacks Equity Research

Walgreens Boots' (WBA) increase in sales at the Retail Pharmacy International segment, on account of the company's strategic tie-ups, along with strength in other businesses buoy optimism.

    Zacks Equity Research

    3 Stocks to Gain as Trump Pulls Plug on Infamous MedTech Tax

    by Zacks Equity Research

    Here take a quick look on three major MedTech companies that are going to make the best out of the recent Tax-Repeal upheaval.

      Zacks Equity Research

      Can Edwards Lifesciences (EW) Stock Continue to Grow Earnings?

      by Zacks Equity Research

      Edwards Lifesciences (EW) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.

        Zacks Equity Research

        Medical Device Industry Outlook - February 2018

        by Zacks Equity Research

        Amid the concerns related to the tax reform, Congress' postponement of the medical device tax for another two years came as a huge relief to industry participants and investors.

          Zacks Equity Research

          Zacks Investment Ideas feature highlights: Alibaba, NVIDIA, Edwards Lifesciences, Sangamo Therapeutics and bluebird bio

          by Zacks Equity Research

          Zacks Investment Ideas feature highlights: Alibaba, NVIDIA, Edwards Lifesciences, Sangamo Therapeutics and bluebird bio

            Zacks Equity Research

            Here's Why You Should Invest in Edwards Lifesciences (EW) Now

            by Zacks Equity Research

            Recent buyouts and CE Mark boost investors' confidence in Edwards Lifesciences (EW).

              Zacks Equity Research

              Edwards Lifesciences' CE Mark for CENTERA Boosts THVT Arm

              by Zacks Equity Research

              Edward Lifesciences (EW) witnesses multiple developments in THV segment.

                Ryan McQueeney headshot

                Markets Are Down, But These Stocks Surged to All-Time Highs Today

                by Ryan McQueeney

                Friday has been a rough day on Wall Street, with several major indexes--including the Dow, Nasdaq, and S&P 500--hovering deep in the red during early afternoon trading hours. Nevertheless, several notable stocks touched new all-time highs during the day. Check them out!

                  Zacks Equity Research

                  Is a Surprise Coming for Edwards Lifesciences (EW) This Earnings Season?

                  by Zacks Equity Research

                  Edwards Lifesciences (EW) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.

                    Zacks Equity Research

                    Edwards Lifesciences' (EW) THVT Likely to Drive Q4 Earnings

                    by Zacks Equity Research

                    Edwards Lifesciences (EW) is expected to gain from strength in THVT on continued therapy adoption across all geographies.

                      Zacks Equity Research

                      Edwards Lifesciences Buys Harpoon Medical, Expands Portfolio

                      by Zacks Equity Research

                      Edwards Lifesciences (EW) expands Surgical Heart Valve Therapy segment with the buyout of Harpoon Medical.

                        Zacks Equity Research

                        Implied Volatility Surging for Edwards Lifesciences (EW) Stock Options

                        by Zacks Equity Research

                        Edwards Lifesciences (EW) needs investors to pay close attention to the stock based on moves in the options market lately.

                          Zacks Equity Research

                          EW vs. BCR: Which Stock is Poised for Better Q3 Earnings?

                          by Zacks Equity Research

                          Political turmoil and the health policy related battle apart, majority of the MedTech stocks' bottom line is likely to be hurt in the third quarter on escalating costs induced by consecutive hurricanes and Mexico earthquakes.

                            Zacks Equity Research

                            Will Edwards Lifesciences (EW) Gain on THVT in Q3 Earnings?

                            by Zacks Equity Research

                            Edwards Lifesciences (EW) will likely ride high in Q3 earnings banking on continued growth in its highly advanced Transcatheter Heart Valve Therapy space.

                              Zacks Equity Research

                              Edwards Lifesciences, Bed Bath & Beyond, Annaly Capital Management, AGNC Investment and ARMOUR Residential REIT highlighted as Zacks Bull and Bear of the Day

                              by Zacks Equity Research

                              Edwards Lifesciences, Bed Bath & Beyond, Annaly Capital Management, AGNC Investment and ARMOUR Residential REIT highlighted as Zacks Bull and Bear of the Day

                                Zacks Equity Research

                                Align Technology (ALGN) Prospects Bright, Competition Rife

                                by Zacks Equity Research

                                Align Technology (ALGN) continues to gain from strong InvisAlign sales amid macroeconomic headwinds.

                                  Kevin Cook headshot

                                  Bull of the Day: Edwards Lifesciences (EW)

                                  by Kevin Cook

                                  The #1 non-surgical heart valve replacement technology owes its roots to a hydraulic pump engineer named Miles Edwards

                                    Zacks Equity Research

                                    Medtronic Advances in Pain Therapy With U.S. Intellis Launch

                                    by Zacks Equity Research

                                    We look forward to a solid customer adoption of Medtronic's (MDT) Intellis platform, considering the vast and expanding market for chronic pain management.

                                      Zacks Equity Research

                                      Here's Why You Should Add Abbott (ABT) to Your Portfolio Now

                                      by Zacks Equity Research

                                      The market is upbeat about Abbott (ABT) acquiring the national reimbursement for FreeStyleLibre glucose monitoring system in the United Kingdom. Several product launches also add value.

                                        Zacks Equity Research

                                        Amedisys or Chemed: Which is a Better Investment Choice?

                                        by Zacks Equity Research

                                        After considering various parameters and fundamentals, we help you make a choice between Amedisys (AMED) and Chemed (CHE).

                                          Zacks Equity Research

                                          Why Should Investors Add Amedisys (AMED) to Their Portfolio?

                                          by Zacks Equity Research

                                          Amedisys (AMED) rides high on solid prospects with new opportunities within home health and hospice services segments.

                                            Zacks Equity Research

                                            Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now

                                            by Zacks Equity Research

                                            IDEXX Laboratories (IDXX) continues to boost investor's confidence with strong companion animal business along with balanced growth across all segments.

                                              Zacks Equity Research

                                              Why is Edwards Lifesciences (EW) a Strong Buy Stock Now?

                                              by Zacks Equity Research

                                              Several recent FDA product-approvals boost investors' trust in Edwards Lifesciences' (EW) stock.

                                                Zacks Equity Research

                                                Here's Why You Should Add Chemed (CHE) to Your Portfolio

                                                by Zacks Equity Research

                                                Chemed (CHE) bolsters investor's confidence with continued strength in Roto-Rooter business.

                                                  Zacks Equity Research

                                                  Here's Why You Should Bet on BioTelemetry (BEAT) Stock Now

                                                  by Zacks Equity Research

                                                  BioTelemetry's (BEAT) consistent efforts in product innovation through research and development buoy optimism. Also, the recent acquisition instills confidence in investors.